FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.xver-r5.r3
Resource TypeValueSet
IdValueSet-R5-research-study-phase-for-R3.json
FHIR VersionR3
Sourcehttp://hl7.org/fhir/uv/xver-r5.r3/0.1.0/ValueSet-R5-research-study-phase-for-R3.html
URLhttp://hl7.org/fhir/uv/xver/ValueSet/R5-research-study-phase-for-R3
Version0.1.0
Statusactive
Date2026-03-17T21:02:03.8104715+00:00
NameR5ResearchStudyPhaseForR3
TitleCross-version ValueSet R5.ResearchStudyPhase for use in FHIR STU3
Realmuv
Authorityhl7
DescriptionThis cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0` for use in FHIR STU3.
PurposeThis value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0` as defined in FHIR R5 in FHIR STU3. The source value set is bound to the following FHIR R5 elements: * `ResearchStudy.phase` as Example Across FHIR versions, the value set has been mapped as: * `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0` * `http://hl7.org/fhir/ValueSet/research-study-phase|4.3.0` * `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1` Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (8). All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (8). FHIR ValueSet `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0`, defined in FHIR R5 does not have any mapping to FHIR STU3

Resources that use this resource

StructureDefinition
hl7.fhir.uv.xver-r5.r3#0.1.0extension-ResearchStudy.phaseR5: n-a | early-phase-1 | phase-1 | phase-1-phase-2 | phase-2 | phase-2-phase-3 | phase-3 | phase-4 (new)

Resources that this resource uses

CodeSystem
hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2research-study-phaseResearchStudy Phase Code System

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet R5-research-study-phase-for-R3

This value set expansion contains 8 concepts.

SystemVersionCodeDisplayDefinition
http://hl7.org/fhir/research-study-phase5.0.0  early-phase-1Early Phase 1Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.
http://hl7.org/fhir/research-study-phase5.0.0  n-aN/ATrials without phases (for example, studies of devices or behavioral interventions).
http://hl7.org/fhir/research-study-phase5.0.0  phase-1Phase 1Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
http://hl7.org/fhir/research-study-phase5.0.0  phase-1-phase-2Phase 1/Phase 2Trials that are a combination of phases 1 and 2.
http://hl7.org/fhir/research-study-phase5.0.0  phase-2Phase 2Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
http://hl7.org/fhir/research-study-phase5.0.0  phase-2-phase-3Phase 2/Phase 3Trials that are a combination of phases 2 and 3.
http://hl7.org/fhir/research-study-phase5.0.0  phase-3Phase 3Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
http://hl7.org/fhir/research-study-phase5.0.0  phase-4Phase 4Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.

Source1

{
  "resourceType": "ValueSet",
  "id": "R5-research-study-phase-for-R3",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 1
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "brr"
    },
    {
      "extension": [
        {
          "url": "packageId",
          "valueId": "hl7.fhir.uv.xver-r5.r3"
        },
        {
          "url": "version",
          "valueString": "0.1.0"
        },
        {
          "url": "uri",
          "valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r5.r3"
        }
      ],
      "url": "http://hl7.org/fhir/StructureDefinition/package-source"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use",
      "_valueCode": {
        "extension": [
          {
            "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r5.r3"
          }
        ]
      }
    }
  ],
  "url": "http://hl7.org/fhir/uv/xver/ValueSet/R5-research-study-phase-for-R3",
  "version": "0.1.0",
  "name": "R5ResearchStudyPhaseForR3",
  "title": "Cross-version ValueSet R5.ResearchStudyPhase for use in FHIR STU3",
  "status": "active",
  "experimental": false,
  "date": "2026-03-17T21:02:03.8104715+00:00",
  "publisher": "Biomedical Research and Regulation",
  "contact": [
    {
      "name": "Biomedical Research and Regulation",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/rcrim"
        }
      ]
    }
  ],
  "description": "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0` for use in FHIR STU3.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001",
          "display": "World"
        }
      ]
    }
  ],
  "purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0` as defined in FHIR R5\r\nin FHIR STU3.\r\n\r\nThe source value set is bound to the following FHIR R5 elements:\r\n* `ResearchStudy.phase` as Example\r\n\r\nAcross FHIR versions, the value set has been mapped as:\r\n* `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0`\n* `http://hl7.org/fhir/ValueSet/research-study-phase|4.3.0`\n* `http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1`\r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (8).\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (8).\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/research-study-phase|5.0.0`, defined in FHIR R5 does not have any mapping to FHIR STU3",
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "concept": [
          {
            "code": "early-phase-1",
            "display": "Early Phase 1"
          },
          {
            "code": "n-a",
            "display": "N/A"
          },
          {
            "code": "phase-1",
            "display": "Phase 1"
          },
          {
            "code": "phase-1-phase-2",
            "display": "Phase 1/Phase 2"
          },
          {
            "code": "phase-2",
            "display": "Phase 2"
          },
          {
            "code": "phase-2-phase-3",
            "display": "Phase 2/Phase 3"
          },
          {
            "code": "phase-3",
            "display": "Phase 3"
          },
          {
            "code": "phase-4",
            "display": "Phase 4"
          }
        ]
      }
    ]
  },
  "expansion": {
    "timestamp": "2026-03-17T21:02:03.8104715+00:00",
    "contains": [
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "early-phase-1",
        "display": "Early Phase 1"
      },
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "n-a",
        "display": "N/A"
      },
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "phase-1",
        "display": "Phase 1"
      },
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "phase-1-phase-2",
        "display": "Phase 1/Phase 2"
      },
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "phase-2",
        "display": "Phase 2"
      },
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "phase-2-phase-3",
        "display": "Phase 2/Phase 3"
      },
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "phase-3",
        "display": "Phase 3"
      },
      {
        "system": "http://hl7.org/fhir/research-study-phase",
        "version": "5.0.0",
        "code": "phase-4",
        "display": "Phase 4"
      }
    ]
  }
}